Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis.

[1]  C. Liapis,et al.  Exercise and carotid atherosclerosis. , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[2]  Spyretta Golemati,et al.  The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability. , 2008, Journal of vascular surgery.

[3]  M. Kaczmarczyk,et al.  Ultrasonographic and histological analysis of atheromatous plaques in carotid arteries and apoplectic complications. , 2007, Medical science monitor : international medical journal of experimental and clinical research.

[4]  J. Kastelein,et al.  Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque? , 2007, Current pharmaceutical design.

[5]  J. Hansen,et al.  Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans , 2007 .

[6]  J. Hansen,et al.  Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans. , 2005, Atherosclerosis.

[7]  G. Maurer,et al.  Statins decrease TNF-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro. , 2007, Biochemical pharmacology.

[8]  A. Wierzbicki.  Lipid-Altering Therapies and the Progression of Atherosclerotic Disease , 2007, CardioVascular and Interventional Radiology.

[9]  J. Higaki,et al.  Osteopontin and carotid atherosclerosis in patients with essential hypertension. , 2006, Clinical science.

[10]  Reiko Ohmori,et al.  Effect of Atorvastatin on Plasma Osteopontin Levels in Patients With Hypercholesterolemia , 2006 .

[11]  Y. Ouchi,et al.  Statins Protect Human Aortic Smooth Muscle Cells From Inorganic Phosphate-Induced Calcification by Restoring Gas6-Axl Survival Pathway , 2006, Circulation research.

[12]  L. Hofbauer,et al.  Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts , 2005, Journal of cellular biochemistry.

[13]  Philippe Douek,et al.  The Vulnerable Carotid Artery Plaque: Current Imaging Methods and New Perspectives , 2005, Stroke.

[14]  L. Chang,et al.  Osteopontin gene expression in the aorta and the heart of propylthiouracil-induced hypothyroid mice. , 2005, Journal of biomedical science.

[15]  Jan Nilsson,et al.  Elastin and Calcium Rather Than Collagen or Lipid Content Are Associated With Echogenicity of Human Carotid Plaques , 2004, Stroke.

[16]  P. Touboul,et al.  Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis , 2004, Stroke.

[17]  P. Collin‐Osdoby.  Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin , 2004, Circulation research.

[18]  Seymour Glagov,et al.  Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation. , 2004, Journal of vascular surgery.

[19]  Y. Tintut,et al.  Vascular calcification: mechanisms and clinical ramifications. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[20]  J. Golledge,et al.  Osteoprotegerin and Osteopontin Are Expressed at High Concentrations Within Symptomatic Carotid Atherosclerosis , 2004, Stroke.

[21]  W. Poewe,et al.  Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease , 2004, Circulation.

[22]  Allen J. Taylor,et al.  Marked low‐density lipoprotein cholesterol reduction below current national cholesterol education program targets provides the greatest reduction in carotid atherosclerosis , 2004, Clinical cardiology.

[23]  A. Alexandrov,et al.  Carotid Artery Stenosis: Grayscale and Doppler Ultrasound Diagnosis—Society of Radiologists in Ultrasound Consensus Conference , 2003, Ultrasound quarterly.

[24]  R Eugene Zierler,et al.  Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. , 2003, Radiology.

[25]  Reiko Ohmori,et al.  Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. , 2003, Atherosclerosis.

[26]  Y. Matsui,et al.  Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E–Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Brian J. Bennett,et al.  Simvastatin Promotes Atherosclerotic Plaque Stability in ApoE-Deficient Mice Independently of Lipid Lowering , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[28]  C. Liapis,et al.  Carotid Stenosis: Factors Affecting Symptomatology , 2001, Stroke.

[29]  P. Geusens,et al.  Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic Plaques , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[30]  K. Yokote,et al.  NK‐104, a 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells , 2001, British journal of pharmacology.

[31]  V. Fuster,et al.  Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. , 2000, Atherosclerosis.

[32]  J M Stevens,et al.  Reproducibility of Computer-Quantified Carotid Plaque Echogenicity: Can We Overcome the Subjectivity? , 2000, Stroke.

[33]  S. Harris,et al.  Stimulation of bone formation in vitro and in rodents by statins. , 1999, Science.

[34]  M. Mayberg,et al.  Carotid endarterectomy for symptomatic carotid stenosis. , 1997, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.